Published in Nucleic Acids Res on July 01, 2000
MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet (2008) 6.00
Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells. Genes Dev (2001) 5.60
Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences. Mol Cell Biol (2003) 3.32
Targeted engineering of the Caenorhabditis elegans genome following Mos1-triggered chromosomal breaks. EMBO J (2006) 2.62
DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc Natl Acad Sci U S A (2004) 2.51
ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining. Cell Cycle (2010) 2.32
Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc Natl Acad Sci U S A (2007) 2.27
Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol (2002) 2.25
Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res (2001) 2.14
Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet (2010) 2.14
Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res (2003) 2.05
The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev (2007) 1.88
Molecular analysis of telomere fusions in Arabidopsis: multiple pathways for chromosome end-joining. EMBO J (2004) 1.72
DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. Nucleic Acids Res (2004) 1.67
The response to and repair of RAG-mediated DNA double-strand breaks. Annu Rev Immunol (2012) 1.64
Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res (2008) 1.43
Microhomology-mediated end joining in fission yeast is repressed by pku70 and relies on genes involved in homologous recombination. Genetics (2007) 1.41
Distinct roles of XRCC4 and Ku80 in non-homologous end-joining of endonuclease- and ionizing radiation-induced DNA double-strand breaks. Nucleic Acids Res (2008) 1.40
Three retrotransposon families in the genome of Giardia lamblia: two telomeric, one dead. Proc Natl Acad Sci U S A (2001) 1.40
Processing of DNA for nonhomologous end-joining by cell-free extract. EMBO J (2005) 1.38
Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway. Mol Cell (2008) 1.38
The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic Acids Res (2010) 1.37
Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res (2008) 1.37
Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol (2003) 1.37
Is non-homologous end-joining really an inherently error-prone process? PLoS Genet (2014) 1.37
The human set and transposase domain protein Metnase interacts with DNA Ligase IV and enhances the efficiency and accuracy of non-homologous end-joining. DNA Repair (Amst) (2008) 1.35
Developmental modulation of nonhomologous end joining in Caenorhabditis elegans. Genetics (2006) 1.33
The Ku heterodimer performs separable activities at double-strand breaks and chromosome termini. Mol Cell Biol (2003) 1.28
Deletion of the Pichia pastoris KU70 homologue facilitates platform strain generation for gene expression and synthetic biology. PLoS One (2012) 1.20
Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements. Nucleic Acids Res (2009) 1.19
Microhomology-dependent end joining and repair of transposon-induced DNA hairpins by host factors in Saccharomyces cerevisiae. Mol Cell Biol (2004) 1.16
Telomere dynamics and fusion of critically shortened telomeres in plants lacking DNA ligase IV. Nucleic Acids Res (2007) 1.15
Alternative end-joining mechanisms: a historical perspective. Front Genet (2013) 1.13
Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair. Biochemistry (2011) 1.10
ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging (Albany NY) (2010) 1.09
The influence of DNA double-strand break structure on end-joining in human cells. Nucleic Acids Res (2001) 1.09
DNA repair of clustered lesions in mammalian cells: involvement of non-homologous end-joining. Nucleic Acids Res (2008) 1.09
Ku heterodimer-independent end joining in Trypanosoma brucei cell extracts relies upon sequence microhomology. Eukaryot Cell (2007) 1.06
End joining at Caenorhabditis elegans telomeres. Genetics (2008) 1.01
Ionizing radiation and restriction enzymes induce microhomology-mediated illegitimate recombination in Saccharomyces cerevisiae. Nucleic Acids Res (2007) 1.01
Lig4 and rad54 are required for repair of DNA double-strand breaks induced by P-element excision in Drosophila. Genetics (2004) 1.00
Capture of linear fragments at a double-strand break in yeast. Nucleic Acids Res (2007) 1.00
The role of DNA polymerase activity in human non-homologous end joining. Nucleic Acids Res (2001) 0.99
Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining. Am J Cancer Res (2012) 0.99
Requirement for XLF/Cernunnos in alignment-based gap filling by DNA polymerases lambda and mu for nonhomologous end joining in human whole-cell extracts. Nucleic Acids Res (2009) 0.99
Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors. Cell Cycle (2013) 0.97
Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn2. Nucleic Acids Res (2013) 0.95
Telomerase-dependent and -independent chromosome healing in mouse embryonic stem cells. DNA Repair (Amst) (2008) 0.95
Genome wide distribution of illegitimate recombination events in Kluyveromyces lactis. Nucleic Acids Res (2006) 0.94
Capture of extranuclear DNA at fission yeast double-strand breaks. Genetics (2005) 0.94
In vitro repair of complex unligatable oxidatively induced DNA double-strand breaks by human cell extracts. Nucleic Acids Res (2001) 0.93
Tolerance for 8-oxoguanine but not thymine glycol in alignment-based gap filling of partially complementary double-strand break ends by DNA polymerase lambda in human nuclear extracts. Nucleic Acids Res (2008) 0.92
The fidelity of the ligation step determines how ends are resolved during nonhomologous end joining. Nat Commun (2014) 0.91
Mutator phenotype of Caenorhabditis elegans DNA damage checkpoint mutants. Genetics (2006) 0.90
Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC. Blood (2010) 0.88
Two-dimensional blue native/SDS-PAGE analysis reveals heat shock protein chaperone machinery involved in hepatitis B virus production in HepG2.2.15 cells. Mol Cell Proteomics (2008) 0.88
The role of nonhomologous end-joining components in telomere metabolism in Kluyveromyces lactis. Genetics (2007) 0.87
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres. EMBO J (2015) 0.86
Structural biology of DNA repair: spatial organisation of the multicomponent complexes of nonhomologous end joining. J Nucleic Acids (2010) 0.84
Chemical and biological approaches to improve the efficiency of homologous recombination in human cells mediated by artificial restriction DNA cutter. Nucleic Acids Res (2012) 0.81
Lack of MSH2 involvement differentiates V(D)J recombination from other non-homologous end joining events. Nucleic Acids Res (2005) 0.78
Cytotoxicity and Genotoxicity Assessment of Sandalwood Essential Oil in Human Breast Cell Lines MCF-7 and MCF-10A. Evid Based Complement Alternat Med (2016) 0.77
Requirement of POL3 and POL4 on non-homologous and microhomology-mediated end joining in rad50/xrs2 mutants of Saccharomyces cerevisiae. Mutagenesis (2015) 0.77
Rad1, rad10 and rad52 mutations reduce the increase of microhomology length during radiation-induced microhomology-mediated illegitimate recombination in saccharomyces cerevisiae. Radiat Res (2009) 0.77
Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications. Curr Genomics (2010) 0.77
Ku and the Stability of the Genome. J Biomed Biotechnol (2002) 0.76
Gene rearrangements induced by the DNA double-strand cleaving agent neocarzinostatin: conservative non-homologous reciprocal exchanges in an otherwise stable genome. Nucleic Acids Res (2002) 0.75
Calcium influx-mediated translocation of m-calpain induces Ku80 cleavage and enhances the Ku80-related DNA repair pathway. Oncotarget (2016) 0.75
Ku protein levels, localization and association to replication origins in different stages of breast tumor progression. J Cancer (2013) 0.75
Efficient gene targeting in non-homologous end-joining-deficient Lipomyces starkeyi strains. Curr Genet (2017) 0.75
Regulation of non-homologous end joining via post-translational modifications of components of the ligation step. Curr Genet (2016) 0.75
Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic Acids Res (1988) 15.37
Genetic and physical linkage of exogenous sequences in transformed cells. Cell (1980) 6.67
Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell (1995) 5.58
Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol Cell Biol (1986) 5.25
Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature (1997) 5.08
Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science (1994) 4.99
DNA end-joining: from yeast to man. Trends Biochem Sci (1998) 4.94
Impairment of V(D)J recombination in double-strand break repair mutants. Science (1993) 4.72
Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways. EMBO J (1996) 4.58
Molecular mechanisms of DNA double strand break repair. Trends Cell Biol (1998) 4.41
Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature (1998) 4.37
Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res (1996) 4.37
The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell (1995) 4.35
Yeast DNA ligase IV mediates non-homologous DNA end joining. Nature (1997) 4.34
Mechanisms of nonhomologous recombination in mammalian cells. Mol Cell Biol (1985) 4.20
Somatic cells efficiently join unrelated DNA segments end-to-end. Mol Cell Biol (1982) 4.13
Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci U S A (1997) 4.13
Altering genotype and phenotype by DNA-mediated gene transfer. Science (1980) 3.82
Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr Biol (1997) 3.67
Two different types of double-strand breaks in Saccharomyces cerevisiae are repaired by similar RAD52-independent, nonhomologous recombination events. Mol Cell Biol (1994) 3.40
DNA end-joining catalyzed by human cell-free extracts. Proc Natl Acad Sci U S A (1998) 3.11
Homologous recombination and the roles of double-strand breaks. Trends Biochem Sci (1995) 3.10
DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. Trends Biochem Sci (1995) 3.01
Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc Natl Acad Sci U S A (1995) 2.99
Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res (1998) 2.89
V(D)J recombination in mammalian cell mutants defective in DNA double-strand break repair. Mol Cell Biol (1993) 2.66
A novel pathway of DNA end-to-end joining. Cell (1990) 2.61
Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks. EMBO J (1998) 2.52
Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA. J Biol Chem (1996) 2.40
DNA looping by Ku and the DNA-dependent protein kinase. Proc Natl Acad Sci U S A (1997) 2.39
Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant. J Biol Chem (1994) 2.30
Joining of nonhomologous DNA double strand breaks in vitro. Nucleic Acids Res (1988) 2.29
X-ray-sensitive mutants of Chinese hamster ovary cell line. Isolation and cross-sensitivity to other DNA-damaging agents. Mutat Res (1983) 2.23
Ku, a DNA repair protein with multiple cellular functions? Mutat Res (1999) 2.16
Efficient processing of DNA ends during yeast nonhomologous end joining. Evidence for a DNA polymerase beta (Pol4)-dependent pathway. J Biol Chem (1999) 2.06
A DNA end-binding factor involved in double-strand break repair and V(D)J recombination. Mol Cell Biol (1994) 2.05
A mechanism for deletion formation in DNA by human cell extracts: the involvement of short sequence repeats. Nucleic Acids Res (1992) 2.03
Studies on mammalian mutants defective in rejoining double-strand breaks in DNA. Mutat Res (1990) 1.97
Homologous, homeologous, and illegitimate repair of double-strand breaks during transformation of a wild-type strain and a rad52 mutant strain of Saccharomyces cerevisiae. Mol Cell Biol (1994) 1.92
Mechanisms of overlap formation in nonhomologous DNA end joining. Mol Cell Biol (1994) 1.91
Cell cycle responses of two X-ray sensitive mutants defective in DNA repair. Int J Radiat Biol (1989) 1.87
Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Mol Cell Biol (1996) 1.75
Isolation of cell cycle-dependent gamma ray-sensitive Chinese hamster ovary cell. Somatic Cell Genet (1983) 1.67
Repair and recombination. How to make ends meet. Curr Biol (1995) 1.64
Molecular and biochemical characterization of xrs mutants defective in Ku80. Mol Cell Biol (1997) 1.62
Illegitimate recombination in Xenopus: characterization of end-joined junctions. Nucleic Acids Res (1994) 1.49
Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur J Biochem (1998) 1.49
Nonhomologous recombination in human cells. Mol Cell Biol (1994) 1.40
Disruption of DNA-PK in Ku80 mutant xrs-6 and the implications in DNA double-strand break repair. Mutat Res (1996) 1.38
A modified single-strand annealing model best explains the joining of DNA double-strand breaks mammalian cells and cell extracts. Nucleic Acids Res (1995) 1.33
Ku-dependent nonhomologous DNA end joining in Xenopus egg extracts. Mol Cell Biol (1999) 1.31
DNA repair. Gatekeepers of recombination. Nature (1999) 1.26
The role of homologous recombination processes in the repair of severe forms of DNA damage in mammalian cells. Biochimie (1999) 1.21
Characterization of DNA end joining in a mammalian cell nuclear extract: junction formation is accompanied by nucleotide loss, which is limited and uniform but not site specific. Mol Cell Biol (1994) 1.20
The joining of non-complementary DNA double-strand breaks by mammalian extracts. Nucleic Acids Res (1996) 1.19
Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol Cell Biol (1997) 1.18
Nonhomologous DNA end joining in Schizosaccharomyces pombe efficiently eliminates DNA double-strand-breaks from haploid sequences. Nucleic Acids Res (1994) 0.99
DNA synthesis on discontinuous templates by DNA polymerase I of Escherichia coli. Gene (1991) 0.97
DNA end joining by the Klenow fragment of DNA polymerase I. J Biol Chem (1996) 0.93
Mechanisms of nonhomologous DNA end-joining in frogs, mice and men. Biol Chem (1996) 0.92
Bridging the gap. Joining of nonhomologous ends by DNA polymerases. J Biol Chem (1994) 0.90
Repair of ionizing radiation damage in mammalian cells. Alternative pathways and their fidelity. C R Acad Sci III (1999) 0.90
Resolution and conservation of mismatches in DNA end joining. Mutagenesis (1994) 0.88
DNA end-joining in extracts from human cells. Biochem Biophys Res Commun (1995) 0.87
Cloning, purification and characterization of DNA polymerase beta from Xenopus laevis--studies on its potential role in DNA-end joining. Eur J Biochem (1998) 0.81
DNA synthesis on discontinuous templates by human DNA polymerases: implications for non-homologous DNA recombination. Nucleic Acids Res (1998) 0.80
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Involvement of reverse transcription in the replication of cauliflower mosaic virus: a detailed model and test of some aspects. Cell (1983) 4.37
A novel pathway of DNA end-to-end joining. Cell (1990) 2.61
Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis (2000) 1.93
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer. Ann Oncol (2013) 1.78
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer. Ann Oncol (2009) 1.58
Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity. J Biol Chem (2001) 1.57
Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur J Biochem (1998) 1.49
Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys (1993) 1.38
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Differential inhibition of downstream gene expression by the cauliflower mosaic virus 35S RNA leader. Virus Genes (1989) 1.30
Aggregation states of brome mosaic virus protein. Virology (1974) 1.29
Structural polymorphism of bromegrass mosaic virus: a neutron small angle scattering investigation. Virology (1978) 1.26
Membrane-associated replication of an unencapsidated double-strand RNA of the fungus, Cryphonectria parasitica. Virology (1993) 1.25
Chromosomal aberrations: formation, identification and distribution. Mutat Res (2002) 1.22
Endonuclease VII of phage T4 triggers mismatch correction in vitro. J Mol Biol (1993) 1.21
Activation of a system for the joining of nonhomologous DNA ends during Xenopus egg maturation. Mol Cell Biol (1992) 1.17
Grapevine fanleaf virus replication occurs on endoplasmic reticulum-derived membranes. J Virol (2002) 1.15
Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2. Arch Microbiol (1984) 1.13
Ultrasonic absorption evidence of structural fluctuations in viral capsids. Proc Natl Acad Sci U S A (1979) 1.11
In vitro expression of cauliflower mosaic virus genes. EMBO J (1988) 1.04
Use of DNA end joining activity of a Xenopus laevis egg extract for construction of deletions and expression vectors for HIV-1 Tat and Rev proteins. Gene (1993) 1.02
Localisation of RAD50 and MRE11 in spermatocyte nuclei of mouse and rat. Chromosoma (2000) 1.01
Radiation-induced brachial plexus neuropathy in breast cancer patients. Acta Oncol (1990) 1.01
Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg (1998) 1.01
Patterns of angiogenesis in nonsmall-cell lung carcinoma. Cancer (2001) 0.99
Transcriptional repression of specific host genes by the mycovirus Cryphonectria hypovirus 1. J Virol (1996) 0.99
Nonhomologous DNA end joining in Schizosaccharomyces pombe efficiently eliminates DNA double-strand-breaks from haploid sequences. Nucleic Acids Res (1994) 0.99
A lytic enzyme cocktail from Streptomyces sp. B578 for the control of lactic and acetic acid bacteria in wine. Appl Microbiol Biotechnol (2009) 0.98
Regulatory O2 tensions for the synthesis of fermentation products in Escherichia coli and relation to aerobic respiration. Arch Microbiol (1997) 0.98
Dramatic changes in the ratio of homologous recombination to nonhomologous DNA-end joining in oocytes and early embryos of Xenopus laevis. Biol Chem Hoppe Seyler (1996) 0.97
Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrations. Cytogenet Genome Res (2004) 0.95
Genetic studies in congenital anterior midline cervical cleft. Am J Med Genet A (2012) 0.95
Isolation of Desulfovibrio intestinalis sp. nov. from the hindgut' of the lower termite Mastotermes darwiniensis. Can J Microbiol (1999) 0.93
Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months. Eur J Cancer (1993) 0.93
Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone. Br J Cancer (2012) 0.93
Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol (1995) 0.92
Mechanisms of nonhomologous DNA end-joining in frogs, mice and men. Biol Chem (1996) 0.92
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. Cancer Chemother Pharmacol (1991) 0.92
[High performance liquid chromatographic determination of organic acids, sugars, glycerin and alcohol in wine on a cation exchange resin]. Z Lebensm Unters Forsch (1985) 0.90
Platinum-based cytotoxic therapy in basal cell carcinoma--a review of the literature. Acta Oncol (1996) 0.90
The structure of cauliflower mosaic virus. II. Identity and location of the viral polypeptides. Virology (1979) 0.88
Phylogenetic analysis of some large double-stranded RNA replicons from plants suggests they evolved from a defective single-stranded RNA virus. J Gen Virol (2000) 0.88
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer. Ann Oncol (2002) 0.87
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies. Eur J Neurol (2014) 0.87
The influence of dsRNA viruses on the biology of plant pathogenic fungi. Trends Microbiol (1999) 0.86
Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients. Eur J Cancer (2012) 0.86
Nonhomologous DNA end joining of synthetic hairpin substrates in Xenopus laevis egg extracts. Nucleic Acids Res (1994) 0.85
The structure of cauliflower mosaic virus. I. pH-induced structural changes. Virology (1979) 0.84
RNA viruses: stabilization of brome mosaic virus. Philos Trans R Soc Lond B Biol Sci (1976) 0.84
Morphometric relationships between tooth and face shapes. J Oral Rehabil (2004) 0.84
Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer. J Clin Oncol (2001) 0.84
The cation binding associated with structural transitions in bromegrass mosaic virus. Virology (1977) 0.83
Radiosensitivity and double-strand break rejoining in tumorigenic and non-tumorigenic human epithelial cell lines. Int J Radiat Biol (1997) 0.83
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. Ann Oncol (2010) 0.82
Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer. Ann Oncol (2013) 0.82
Genetic dependence of IgE antibody production in mice infected with the nematode Nippostronglyus brasiliensis. I. Modulation of the IgE antibody response in vivo by serum factors. Int Arch Allergy Appl Immunol (1983) 0.82
Clinical and electrodiagnostic findings in breast cancer patients with radiation-induced brachial plexus neuropathy. Acta Neurol Scand (1990) 0.81
The role of immunoglobulin E receptors in allergic diseases. Arzneimittelforschung (1985) 0.81
Cloning, purification and characterization of DNA polymerase beta from Xenopus laevis--studies on its potential role in DNA-end joining. Eur J Biochem (1998) 0.81
A brief history and current status of metal-and ceramic surface-conditioning concepts for resin bonding in dentistry. Quintessence Int (1998) 0.81
The distribution of group I introns in lichen algae suggests that lichenization facilitates intron lateral transfer. Mol Phylogenet Evol (2000) 0.80
Development of agro-environmental scenarios to support pesticide risk assessment in Europe. Sci Total Environ (2008) 0.80
Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies. Acta Oncol (1997) 0.80
The double-stranded RNA associated with the '447' cytoplasmic male sterility in Vicia faba is packaged together with its replicase in cytoplasmic membranous vesicles. Plant Mol Biol (1990) 0.79
No evidence of gemcitabine accumulation during weekly administration. Eur J Clin Pharmacol (2005) 0.79
Beta-1,3-glucanase from Delftia tsuruhatensis strain MV01 and its potential application in vinification. Appl Environ Microbiol (2010) 0.78
Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study. Ann Oncol (2009) 0.78
Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab. Ann Oncol (2009) 0.78
Re: five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst (1997) 0.78
UFT (tegafur-uracil) in rectal cancer. Ann Oncol (2008) 0.78
[Immunopathology of the upper respiratory tract]. Arch Otorhinolaryngol Suppl (1987) 0.78
Effect of tooth preparation design on bond strengths of resin-bonded prostheses: a pilot study. J Prosthet Dent (1997) 0.78
Presence of urokinase plasminogen activator, its inhibitor and receptor in small cell lung cancer and non-small cell lung cancer. Int J Oncol (1997) 0.77
[Quantitative methylation-specific PCR for the diagnosis of lung cancer]. Pathologe (2007) 0.77
First experiences with resin-bonded bridges and splints--a cross-sectional retrospective study, Part II. J Oral Rehabil (1988) 0.77
Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer. Breast (2012) 0.77
Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2. Anticancer Res (1998) 0.77
[Temperature loading of resin-bonded bridges and its effect on the composite strength of the adhesive bond]. Schweiz Monatsschr Zahnmed (1989) 0.77
Dihydroorotate (dhout) and orotate (orout) utilizer mutants in yeast: identification of the dhout mutation and allelism of the DHO and URE2 genes. C R Acad Sci III (1998) 0.76
Success rate experience after rebonding and renewal of resin-bonded fixed partial dentures. J Prosthet Dent (1990) 0.76
Interaction of monoclonal antibodies with the IgE-receptor on rat mast cells and rat basophilic leukemia (RBL) cells. Agents Actions (1986) 0.76
Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer. Br J Cancer (2008) 0.76
The effect of conformational changes in brome mosaic virus upon its sensitivity to trypsin, chymotrypsin and ribonuclease. FEBS Lett (1975) 0.76
Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer. Eur J Cancer (2012) 0.76
DNA lesions and repair. Mutat Res (1996) 0.76
[Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers]. Verh Dtsch Ges Pathol (2003) 0.76
[Incidence of dental, mouth, and jaw injuries and the efficacy of mouthguards in top ranking athletes]. Sportverletz Sportschaden (2000) 0.75
[Specific adhesive bonding of air-brushed alloy surfaces]. Dtsch Zahnarztl Z (1989) 0.75